MaaT Pharma SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 1.38 million compared to EUR 0.494 million a year ago. Net loss was EUR 8.44 million compared to EUR 7.42 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.34 EUR | -1.27% | -0.64% | +33.81% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.81% | 117M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MAAT Stock
- News MaaT Pharma
- MaaT Pharma SA Reports Earnings Results for the Half Year Ended June 30, 2023